Amyloid-β induces chemokine secretion and monocyte migration across a human blood-brain barrier model

Molecular Medicine

Volumn 4, Issue 7, 1998, Pages 480-489

  Fiala, Milan ^a   Zhang, Ling ^a   Gan, Xiaohu ^a   Sherry, Barbara ^b   Taub, Dennis ^c   Graves, Michael C ^a   Hama, Suzan ^a   Way, Dennis ^d   Weinand, Martin ^d   Witte, Marlys ^d   Lorton, Diane ^e   Kuo, Yu Min ^e   Roher, Alex E ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Picower Institute Press 350   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CHEMOKINE; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

EID: 7344246592     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401753     Document Type: Article

References (55)

1. Wisniewski HM, Wegiel J, Wang KC, Kujawa M, Lach B. (1989) Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci. 16: 535-542.
2. Glenner GG, Wang CW. (1984) Alzheimer's disease: Initial report of the purification and characteristics of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890.
3. Kidd M. (1963) Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197: 192-193.
4. Guo Q, Sopher BL, Furukawa K, Pham DG, Robinson N, Martin GM, Mattson MP. (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid-β-peptide: Involvement of calcium and oxyradicals. J. Neurosci. 17: 4212-4222.
5. McGeer PL, McGeer EG. (1995) The inflammatory response system of the brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21: 195-218.
6. Rogers J, O'Barr S. (1997) Inflammatory mediators in Alzheimer's Disease. In: Wasco W, Tanzi RE (eds). Molecular Mechanisms of Dementia. Humana Press, Totowa, NJ, pp. 177-198.
7. Haga S, Akai K, Ishii T. (1989) Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. Acta Neuropathol. 77: 569-575.
8. Mackenzie IRA, Hao CH, Munoz DG. (1995) Role of microglia in senile plaque formation. Neurobiol. Aging 16: 797-804.
9. Perlmutter LS, Scott SA, Barron E, Chui HC. (1992) MHC class II-positive microglia in human brain: Association with Alzheimer lesions. J. Neurosci. Res. 33: 549-558.
10. Butter C, Baker D, O'Neill JK, Turk JL. (1991) Mononuclear cell trafficking and plasma protein extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice. J. Neurol. Sci. 104: 9-12.
11. Fluegel A, Kreutzberg GW, Graeber MB. (1998) Transformation of bone marrow-derived macrophages into ramified microglia during autoimmune inflammation of the axoiomized rat facial nucleus. Presented at the Fifth International Congress of Neuroimmunology, Montreal, Canada.
12. Bell MD, Taub DD, Perry VH. (1996) Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 74: 283-292.
13. Petito CK. (1979) Early and late mechanisms of increased vascular permeability following experimental cerebral infarction. J. Neuropathol. Exp. Neurol. 38: 222-234.
14. Plateel M, Teissier E, Cecchelli R. (1997) Hypoxia dramatically increases the nonspecific transport of blood-borne proteins to the brain. J. Neurochem. 68: 874-877.
15. Buee L, Hof PR, Delacourte A. (1997) Brain microvascular changes in Alzheimer's disease and other dementias. Ann. N.Y. Acad. Sci. 826: 7-24.
16. Kalaria RN. (1997) Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Ann. N.Y. Acad. Sci. 826: 263-271.
17. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Cowing E, Ball MJ. (1993) β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90: 10836-10840.
18. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M. (1997) A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158: 3499-3510.
19. Fiala M, Looney DJ, Stins M, Way D, Zhang L, Gan X, Chiappelli F, Shapshak P, Weinand M, Graves M, Witte M, Kim K-S. (1997) TNF-α opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 3: 553-564.
20. Fogelman AM, Elahi F, Sykes K, Van Lenten BJ, Territo MC, Berliner JA. (1988) Modification of the Recalde method for the isolation of human monocytes. J. Lipid Res. 29: 1243-1247.
21. Gan X-H, Robin JP, Huerta JMM, Braquet P, Bonavida B. (1994) Inhibition of TNF-α and IL-1β secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative. Clin. Immunol. 14: 280-288.
22. Schmidtmayerova N, Nottet HSLM, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B. (1996) HIV-1 infection alters chemokine β peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. U.S.A. 93: 700-704.
23. Fiala M, Rhodes RH, Shapshak P, Nagano I, Martinez OM, Diagne A, Baldwin G, Graves M. (1996) Regulation of HIV infection in astrocytes: Expression of Nef, TNF-alpha and IL-6 is enhanced in coculture of astrocytes with macrophages. J. Neurovirol. 2: 158-166.
24. Uchihara T, Akiyama H, Kondo H, Ikeda K. (1997) Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain. Stroke 28: 1948-1950.
25. Sheng JG, Mrak RE, Griffin WS. (1997) Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. 94: 1-5.
26. Ishizuka K, Kimura T, Igata-yi R, Katsuragi S, Takamatsu J, Miyakawa T. (1997) Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin. Neurosci. 51: 135-138.
27. Dickson DW, Sinicropi S, Yen SH, Ko LW, Mattiace LA, Bucala R, Vlassara H. (1996) Glycation and microglial reaction in lesions of Alzheimer's disease. Neurobiol. Aging 17: 733-743.
28. Eikelenboom P, Veerhuis R. (1996) The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 17: 673-680.
29. Kalaria RN, Harshbarger-Kelly M, Cohen DL, Premkumar DR. (1996) Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Neurobiol. Aging 17: 687.
30. Mirra SS, Hart MN, Terry RD. (1993) Making the diagnosis of Alzheimer's disease. A primer for practicing pathologisls. Arch. Pathol. Lab. Med. 117: 132-144.
31. Lue LF, Brachova L, Civin WH, Rogers J. (1996) Inflammation, Aβ deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J. Neuropathol. Exp. Neurol. 55: 1083-1088.
32. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, et al. (1995) Alzheimertype neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373: 523-527.
33. Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, Cole GM. (1998) Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152: 307-317.
34. Egensperberger R, Koesel S, von Eitzen U, Graeber MB. (1998) Microglial activation in Alzheimer disease: Association with APOE genotype. Brain Pathol. 8: (in press).
35. Saunders AM, Strittmatter WJ, Schmechel D, St Geoge-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Golgaber D, Roses AD. (1993) Association of apolipoprotein E allele ε-4 with late onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
36. Brachova L, Walker D, Rogers, J. (1996) Alzheimer's disease and nondemented elderly glial cultures: Constitutive and stimulated expression of complement, cytokines, and apolipoprotein E. Neurobiol. Aging (Suppl.) 17: S20.
37. Lue LF, Brachova L, Rogers, J. (1997) Modeling Aβ deposition in cultures of Alzheimer's glia and HNT neurons. Soc. Neurosci. Abstr. 23: 533.
38. Miyakawa T, Uehara Y. (1979) Observations of amyloid angiopathy and semile plaques by the scanning electron microscope. Acta Neuropathol. 48: 153-156.
39. Sievers J, Parwaresch R, Wottge H-U. (1994) Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: Morphology. Glia 12: 245-258.
40. Giulian D, Li J, Bartel S, Broker J, Li X, Kirkpatrick JB. (1995) Cell surface morphology identifies microglia as a distinct class of mononuclear phagocyte. J. Neurosci. 15: 7712-7726.
41. Seebach J, Bartholdi D, Frei K, Spanaus KS, Ferrero E, Widmer U, Isenmann S, Stricter RM, Schwab M, Pfister H, et al. (1995) Experimental Listeria meningoencephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J. Immunol. 155: 4367-4375.
42. Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, Sharer LR, McComb RD, Swindells S, Soderland C, Gendelman HE. (1996) Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156: 1284-1295.
43. Persidsky Y, Gendelman HE. (1997) Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia. J. Leukoc. Biol. 62: 100-106.
44. Hickey WF. (1991) Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1: 97-105.
45. Belayev L, Busto R, Zhao W, Ginsberg MD. (1996) Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739: 88-96.
46. Shaver SW, Wall KM, Wainman DS, Gross PM. (1992) Regional quantitative permeability of blood-brain barrier lesions in rats with chronic renal hypertension. Brain Res. 579: 99-106.
47. Barzo P, Marmarou A, Fatouros P, Corwin F, Dunbar JG. (1997) Acute blood-brain barrier changes in experimental closed head injury as measured by MRI and Gd-DTPA. Acta Neurochir. Suppl. 70: 243-246.
48. dela Torre JC, Mussivand T. (1993) Can disturbed brain microcirculation cause Alzheimer's disease. Neurol. Res. 15: 146-153.
49. Shah GN, Mooradian AD. (1997) Age-related changes in the blood-brain barrier. Exp. Gerontol. 32: 501-519.
50. Hardy JA, Mann DMA, Wester P, Winblad B. (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol. Aging 7: 489-502.
51. Zlokovic BV, Martel CL, Matsubara E, McComb JG, Zheng G, McCluskey RT, Frangione B, Ghiso J. (1996) Glycoprotein 330/megalin: Probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. U.S.A. 93: 4229-4234.
52. Zlokovic BV. (1996) Cerebral vascular transport of Alzheimer's amyloid β and apolipoproteins J and E: Possible anti-amyloidogenic role of the bloodbrain barrier. Life Sci. 59: 1483-1497.
53. Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ. (1996) Amyloid β-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271: 32916-32922.
54. Hughes SR, Khorkova O, Goyal S, Knaeblein J, Heroux J, Riedel NG, Sahasrabudhe S. (1998) α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. U.S.A. 95: 3275-3280.
55. Tsuzuki K, Fukatsu R, Hayashi Y, Yoshida T, Sasaki N, Takamaru Y, Yamaguchi H, Tateno M, Fujii N, Takahata N. (1997) Amyloid β protein and transthyretin, sequestrating protein colocalize in normal human kidney. Neurosci. Lett. 222: 163-166.